BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15254681)

  • 1. Melanoma metastasis is associated with enhanced expression of the syntenin gene.
    Helmke BM; Polychronidis M; Benner A; Thome M; Arribas J; Deichmann M
    Oncol Rep; 2004 Aug; 12(2):221-8. PubMed ID: 15254681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the heat shock cognate protein HSP73 correlates with tumour thickness of primary melanomas and is enhanced in melanoma metastases.
    Deichmann M; Polychronidis M; Benner A; Kleist C; Thome M; Kahle B; Helmke BM
    Int J Oncol; 2004 Aug; 25(2):259-68. PubMed ID: 15254721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syntenin is overexpressed and promotes cell migration in metastatic human breast and gastric cancer cell lines.
    Koo TH; Lee JJ; Kim EM; Kim KW; Kim HD; Lee JH
    Oncogene; 2002 Jun; 21(26):4080-8. PubMed ID: 12037664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
    Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M
    Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of EphB6 expression in metastatic melanoma.
    Hafner C; Bataille F; Meyer S; Becker B; Roesch A; Landthaler M; Vogt T
    Int J Oncol; 2003 Dec; 23(6):1553-9. PubMed ID: 14612926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tandem PDZ domains of syntenin promote cell invasion.
    Meerschaert K; Bruyneel E; De Wever O; Vanloo B; Boucherie C; Bracke M; Vandekerckhove J; Gettemans J
    Exp Cell Res; 2007 May; 313(9):1790-804. PubMed ID: 17451681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syntenin: a novel PDZ domain-containing scaffolding protein associated with human melanoma metastasis.
    Yang JB; McCarthy JB
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 32(2):204-12. PubMed ID: 17478924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues.
    Jaeger J; Koczan D; Thiesen HJ; Ibrahim SM; Gross G; Spang R; Kunz M
    Clin Cancer Res; 2007 Feb; 13(3):806-15. PubMed ID: 17289871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases.
    Becker B; Multhoff G; Farkas B; Wild PJ; Landthaler M; Stolz W; Vogt T
    Exp Dermatol; 2004 Jan; 13(1):27-32. PubMed ID: 15009113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cDNA-array profiling of melanomas and paired melanocyte cultures.
    Mischiati C; Natali PG; Sereni A; Sibilio L; Giorda E; Cappellacci S; Nicotra MR; Mariani G; Di Filippo F; Catricalà C; Gambari R; Grammatico P; Giacomini P
    J Cell Physiol; 2006 Jun; 207(3):697-705. PubMed ID: 16523488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of melastatin mRNA expression in melanocytic tumors.
    Deeds J; Cronin F; Duncan LM
    Hum Pathol; 2000 Nov; 31(11):1346-56. PubMed ID: 11112208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein B61 as a new growth factor: expression of B61 and up-regulation of its receptor epithelial cell kinase during melanoma progression.
    Easty DJ; Guthrie BA; Maung K; Farr CJ; Lindberg RA; Toso RJ; Herlyn M; Bennett DC
    Cancer Res; 1995 Jun; 55(12):2528-32. PubMed ID: 7780963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression patterns of S100 proteins in melanocytes and melanocytic lesions.
    Petersson S; Shubbar E; Enerbäck L; Enerbäck C
    Melanoma Res; 2009 Aug; 19(4):215-25. PubMed ID: 19521263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of Flotillin-2 is associated with melanoma progression and modulates expression of the thrombin receptor protease activated receptor 1.
    Hazarika P; McCarty MF; Prieto VG; George S; Babu D; Koul D; Bar-Eli M; Duvic M
    Cancer Res; 2004 Oct; 64(20):7361-9. PubMed ID: 15492257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of metastasis-associated genes by transcriptional profiling of a metastasizing versus a non-metastasizing human melanoma cell line.
    Brem R; Hildebrandt T; Jarsch M; Van Muijen GN; Weidle UH
    Anticancer Res; 2001; 21(3B):1731-40. PubMed ID: 11497253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mda-9/Syntenin regulates the metastatic phenotype in human melanoma cells by activating nuclear factor-kappaB.
    Boukerche H; Su ZZ; Emdad L; Sarkar D; Fisher PB
    Cancer Res; 2007 Feb; 67(4):1812-22. PubMed ID: 17308124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of differentially expressed genes in oral squamous cell carcinoma.
    Arora S; Matta A; Shukla NK; Deo SV; Ralhan R
    Mol Carcinog; 2005 Feb; 42(2):97-108. PubMed ID: 15599930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
    Boyd AS; Shakhtour B; Shyr Y
    J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signaling networks in cutaneous melanoma metastasis identified by complementary DNA microarrays.
    Nambiar S; Mirmohammadsadegh A; Doroudi R; Gustrau A; Marini A; Roeder G; Ruzicka T; Hengge UR
    Arch Dermatol; 2005 Feb; 141(2):165-73. PubMed ID: 15724012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.